Djokovic Owned Biotech Firm Aims To Prevent COVID Virus From Infecting Human Cells Using Peptide Therapy

Quite the controversial figure at present, Novak Djokovic owns 80% stake in a Biotech firm QuantBioRes working on the cure for COVID. Centered in Copenhagen, the company is working on a peptide therapy for Covid-19 that will prevent the virus from infecting human cells.

Novak Djokovic, the men's tennis champion, has returned to Belgrade with his family after being deported from Australia last week.

Djokovic and his wife own an 80 percent ownership in Danish biotech firm QuantBioRes, which is focusing on creating a cure for SARS-CoV-2, according to Reuters. Djokovic and his wife have unwittingly (or not) become the focal point of the international discussion around mandatory vaccines.

Ivan Loncarevic, the CEO of QuantBioRes, has characterized himself as an entrepreneur, claiming that Djokovic bought an 80 percent ownership in the company in June 2020, but declining to specify how much he paid for it.

According to the company, it employs roughly a dozen researchers i...

Limited Time

Full Access

$10
Monthly

Included:

  • Access to All Articles.
  • One Plan. No Tiers.
  • No Ads.
  • Cancel anytime.
register now

 
Do you have a tip or sensitive material to share with GGI? Are you a journalist, researcher or independent blogger and want to write for us? You can reach us at [email protected].